Ophthalmology News

Adalimumab combined with corticosteroids led to a significantly lower rate of relapse in Behçet’s disease uveitis vs. cyclosporine alongside corticosteroids, according to data published in The Lancet Rheumatology.

In this edition, enrollment and dosing complete in phase 1 trial of AIV007, popular benchmarks in clinical practice guidelines and more.

Medicine was an interesting thought as I was growing up with no medical people in my family.

An AI model was able to identify several common eye diseases in children using cell phone photos that could be taken at home, researchers reported in JAMA Pediatrics.

In this edition, sozinibercept combination therapy shows durability, comparable improvements with aflibercept and more.

A generally healthy 42-year-old female presents for evaluation of anxiety, tremors, weight loss, loose stools and heart racing. Symptoms began shortly after she was let go at work about 4 months ago.

In this edition, FDA approves Vabysmo prefilled syringe for retinal diseases, 4D Molecular Therapeutics updates on retinal disease candidates and more.

Semaglutide was associated with an increased risk for nonarteritic anterior ischemic optic neuropathy — a form of optic neuropathy that can cause blindness — in adults with type 2 diabetes or obesity, recent data show.

In this edition, AI model helps predict anti-VEGF response in DME, Merck to acquire EyeBio and more.